Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Corti

Showing results (141-150 of 202) with videos related to

Pageof 21
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2019
In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika VirusRianne N Esquivel, Ami Patel, Sagar B Kudchodkar, et al.
Cell Reports. Medicine|August 17, 2022
Antibody therapy reverses biological signatures of COVID-19 progressionM Cyrus Maher, Leah B Soriaga, Anil Gupta, et al.
Nature|May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature Communications|March 2, 2026
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza virusesSaya Moriyama, Julia di Iulio, Fabrizia Zatta, et al.
Iscience|June 5, 2023
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutationsCamilla Tiezzi, Andrea Vecchi, Marzia Rossi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responsesGuillaume B E Stewart-Jones, Jason Gorman, Li Ou, et al.
Nature|August 31, 2021
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodiesFlorian A Lempp, Leah B Soriaga, Martin Montiel-Ruiz, et al.
Research Square|February 17, 2021
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodiesMichael Diamond, Rita Chen, Xuping Xie, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Journal of Hepatology|July 17, 2023
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Pageof 21

Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2019
In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika VirusRianne N Esquivel, Ami Patel, Sagar B Kudchodkar, et al.
Cell Reports. Medicine|August 17, 2022
Antibody therapy reverses biological signatures of COVID-19 progressionM Cyrus Maher, Leah B Soriaga, Anil Gupta, et al.
Nature|May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyDora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature Communications|March 2, 2026
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza virusesSaya Moriyama, Julia di Iulio, Fabrizia Zatta, et al.
Iscience|June 5, 2023
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutationsCamilla Tiezzi, Andrea Vecchi, Marzia Rossi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responsesGuillaume B E Stewart-Jones, Jason Gorman, Li Ou, et al.
Nature|August 31, 2021
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodiesFlorian A Lempp, Leah B Soriaga, Martin Montiel-Ruiz, et al.
Research Square|February 17, 2021
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodiesMichael Diamond, Rita Chen, Xuping Xie, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Journal of Hepatology|July 17, 2023
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Pageof 21